12-61867361-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_178539.5(TAFA2):c.65C>A(p.Thr22Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,608,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178539.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000665 AC: 1AN: 150356Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000400 AC: 1AN: 250104 AF XY: 0.00000740 show subpopulations
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1458130Hom.: 0 Cov.: 29 AF XY: 0.0000248 AC XY: 18AN XY: 725538 show subpopulations
GnomAD4 genome AF: 0.00000665 AC: 1AN: 150356Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73304 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.65C>A (p.T22N) alteration is located in exon 2 (coding exon 1) of the FAM19A2 gene. This alteration results from a C to A substitution at nucleotide position 65, causing the threonine (T) at amino acid position 22 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at